Australia Launches Anti-Vaping Campaign

By Saba Shafiq

| Published Nov 28, 2023 | 12:18 p.m.

The Health Minister said on Tuesday that Australia will prohibit the importation of disposable vapes starting in January. This is the first action in a campaign to stop young people from becoming addicted to these nicotine-filled gadgets.

Health Minister Mark Butler stated in a statement that the Office of Drug Control will provide permits to importers of vapes for medicinal purposes. The prohibition will be extended in March to cover all non-therapeutic vapes, including refillable

devices.

In order to police the new regulations, the Australian Border Force and the Therapeutic Goods Administration will get an additional A$75 million in funds as part of the legislative package.

Next year, additional laws will subject domestic producers to the same bans.

The Australian Health Minister said during a press conference, "These are the vapes that have pink unicorns on them, bubblegum flavoring, disguised so they can hide them in their pencil cases."

"This is not a medicinal product to assist reformed smokers in quitting." This product is specifically marketed to children in an effort to get them addicted to nicotine.

Australia has one of the lowest smoking rates within the OECD, a collection of primarily wealthy nations, but vaping is rising quickly there, especially among the youth. Based on official data, around one in five individuals between the ages of 18 and 24 vape.

The goal of the modifications, which were first announced in August, is to reduce the device's appeal in light of studies that raise concerns about possible long-term damage.

In order to make sure that smokers who want to stop may still access the products, physicians and nurses will have more authority starting in January to recommend therapeutic vapes when it is clinically necessary.

However, under new regulations that will be implemented next year, therapeutic vapes will be prohibited from utilizing flavors, have regulated nicotine levels, and be supplied in pharmaceutical packaging. Manufacturers will have a grace period to comply with these requirements.